The global albumin (as excipient) market was valued at US$ 0.81 billion in 2021. The market is projected to expand at a CAGR of 6.3% from 2022 to 2031, reaching more than US$ 1.7 billion by the end of 2031. Increasing use of albumin as a stabilizing agent, carrier protein, and formulation component in biologics and pharmaceutical products is driving market growth worldwide. Albumin-based...